Article Details

AstraZeneca antibody cocktail succeeds in late-stage study to treat COVID-19 | Financial Post

Retrieved on: 2021-10-11 09:22:30

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca antibody cocktail succeeds in late-stage study to treat COVID-19 | Financial Post. View article details on hiswai:

Excerpt

AstraZeneca's experimental COVID-19 drug has helped cut the risk of severe disease or death in a late-stage study, the British drugmaker said on Monday, ...

Article found on: financialpost.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up